Cervical cancer could be eliminated by 2048, but only in high-income countries, according to a study published May 2 in The Lancet.
Researchers from international academic institutions, including Boston-based Massachusetts General Hospital and Harvard Medical School, projected future cervical cancer incidence for 67 low- and lower-middle-income countries and 42 high-income countries based on different human papillomavirus vaccination and screening scenarios.
Here are three things to know from the study:
- If vaccination and screening rates remain as they are currently, researchers projected cervical cancer would decrease by 23% in low- and lower-middle-income countries and reach elimination status in high-income countries by 2048.
- Low- and lower-middle-income countries would need to reach 90% vaccination coverage among girls to reduce this inequality.
- “Reaching World Health Organization vaccination and screening elimination targets or introducing universal vaccination with high coverage is necessary to eliminate cervical cancer in low- and lower-middle-income countries,” the study authors wrote.
Read the full study here.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
